PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
CorEvitas
Study ID
NCT07648602
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Observational (Non-Interventional) Registry — OTHER
    This is an observational (non-interventional) registry

Study Details

This is a 24-week prospective, single-arm cohort, study of patients initiating advanced therapy for the treatment of moderate-to-severe plaque PSO. Eligible patients must be willing to be seen in-person by their treating physician for a Baseline visit (with first dose of the advanced therapy occurring within 14 days), and at 16 (+/- 5 days) and 24 weeks (+14 days) calculated based on date of first dose of the advanced therapy and must provide informed consent prior to enrolling in the study or completing study-specific questionnaires or procedures. Data will be collected from both subjects and their treating dermatology provider at predetermined scheduled intervals (Baseline, Week 16 and Week 24) using a structured and standardized data collection tool.

Key Dates

Start date
Jun 1, 2026
Status verified
Jun 2026
Primary completion
Dec 31, 2036
Completion
Dec 31, 2036

Study Design

Enrollment
2,500 participants (estimated)

Primary Outcome Measure

Creation of a cohort of psoriasis subjects [ Time Frame: Baseline (Day 0), Week 16 and 24 weeks after initiation of advanced therapy ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
CorEvitas, LLCWalthamMassachusetts02451
Regulatory Corevitas
[email protected]
CorEvitas, LLCWalthamMassachusetts02451
Cathy Cheney
[email protected]
508-555-1212
[email protected]
508-555-1212

Find similar trials in Waltham, MA

By condition
Psoriasis
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
CorEvitas, LLC· Waltham, MA

Related Studies